BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
NA - Nord America 979
EU - Europa 472
AS - Asia 170
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.623
Nazione #
US - Stati Uniti d'America 975
IE - Irlanda 195
CN - Cina 89
IT - Italia 70
SE - Svezia 52
DE - Germania 50
SG - Singapore 37
UA - Ucraina 35
TR - Turchia 32
GB - Regno Unito 20
FR - Francia 17
FI - Finlandia 15
CZ - Repubblica Ceca 6
VN - Vietnam 6
IN - India 5
BE - Belgio 4
CA - Canada 2
ES - Italia 2
AL - Albania 1
AT - Austria 1
DK - Danimarca 1
EU - Europa 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.623
Città #
Chandler 285
Dublin 195
Jacksonville 157
Boardman 58
Ashburn 51
New York 37
L'aquila 30
Lawrence 28
Princeton 28
Singapore 26
Wilmington 26
Izmir 21
Nanjing 21
San Mateo 15
L’Aquila 13
Ann Arbor 11
Dearborn 10
Des Moines 10
Woodbridge 10
Beijing 9
Kitzingen 9
Washington 9
Mountain View 8
Seattle 8
Shanghai 8
Brno 6
Dong Ket 6
Los Angeles 6
Milan 6
Nanchang 6
Dallas 5
Helsinki 5
Munich 5
Ningbo 5
Brussels 4
Hangzhou 4
Pune 4
Rome 4
Shenyang 4
Bremen 3
Edinburgh 3
Grafing 3
Hebei 3
Hefei 3
Houston 3
Jiaxing 3
Kunming 3
Norwalk 3
Verona 3
Changchun 2
Changsha 2
Civitella Messer Raimondo 2
Fremont 2
Novara 2
Redwood City 2
Tianjin 2
Zhengzhou 2
Auburn Hills 1
Auckland 1
Barcelona 1
Boston 1
Bournemouth 1
Brindisi 1
Casal di Principe 1
Cedar Knolls 1
Cormeilles-en-Parisis 1
Fairfield 1
Focsani 1
Forest City 1
Frankfurt am Main 1
Guangzhou 1
Harbin 1
Isernia 1
Jinan 1
Lanzhou 1
Lappeenranta 1
Madrid 1
Manila 1
Odesa 1
Padova 1
Paris 1
Philadelphia 1
San Francisco 1
San Juan 1
Smithers 1
Taizhou 1
Thunder Bay 1
Tirana 1
Vienna 1
Ürümqi 1
Totale 1.232
Nome #
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 94
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 91
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 90
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 82
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 77
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 73
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 71
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 70
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 66
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 64
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 62
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 59
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 57
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 57
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 54
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 51
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 50
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 49
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 47
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 45
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 44
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 43
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 41
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 41
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 40
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 40
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 39
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 32
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 30
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 10
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 10
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 10
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 9
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 6
Totale 1.704
Categoria #
all - tutte 8.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 14 2 5 25 23 6 17 2 4 51
2020/2021225 6 23 0 27 37 9 28 5 33 8 38 11
2021/2022163 5 5 24 9 2 4 0 5 11 22 15 61
2022/2023666 57 54 17 96 37 73 0 39 249 3 27 14
2023/2024214 30 4 14 11 19 66 1 15 3 5 16 30
2024/202586 33 13 40 0 0 0 0 0 0 0 0 0
Totale 1.704